John W. Ostrominski, MD, is a fellow in Cardiovascular Medicine and Obesity Medicine at Brigham and Women’s Hospital and Harvard Medical School.
New FINEARTS-HF Findings Provide Clarity on Balancing Risk and Benefit in HF, CKD
At the American College of Cardiology 2025 Annual Scientific Session, John W. Ostrominski, MD, of Brigham and Women’s Hospital, dives into the nuanced safety profile of finerenone for high-risk patients with heart failure.